Johnson & Johnson partners with BARDA to fund $1 billion in COVID-19 vaccine research

Pharmaceutical giant Johnson & Johnson is partnering with the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services to fund over $1 billion in COVID-19 vaccine and antiviral treatment research and development , the company said on Monday. The partnership is an expansion […]

Click here to view original web page at techcrunch.com

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.